Ambulatory Surgery Centers (ASCs) are increasingly recognized as a pivotal solution in the future of healthcare, offering cost-effective, high-quality surgical care. Kemal Erkan, Chairman of the Board at American Surgery Center and CEO of United Medical, emphasized the significant potential of ASCs in reducing healthcare costs. According to Erkan, hospitals should focus their resources on more severe cases, leaving less complex surgeries to be performed in the outpatient setting of ASCs. He highlighted that directing patients away from traditional hospital settings could potentially reduce surgical costs by up to 59%, benefiting payers and healthcare systems as a whole.
A major advantage of ASCs, as Erkan pointed out, is the financial benefit for surgeons. Unlike hospitals, which charge facility fees for outpatient surgeries, ASCs offer a more financially attractive arrangement for surgeons. These centers provide surgeons with the ability to perform outpatient surgeries without the additional facility fees, making them an appealing option for those looking to optimize both costs and their practice.
The growing prominence of ASCs is reflected in both the economic outlook and the strategic initiatives within the healthcare sector. The global ambulatory surgical centers market, valued at USD 105.58 billion in 2024, is expected to grow to USD 183.1 billion by 2034, driven by the increasing number of surgeries, the growing demand for outpatient settings, and continuous technological advancements in surgical care. This market is projected to grow at a compound annual growth rate (CAGR) of 5.66% from 2025 to 2034, underscoring the strong and sustained growth of ASCs within the healthcare industry.
Get All the Details on Our Solutions – Brochure Download @ https://www.towardshealthcare.com/download-brochure/5021
This growth is further highlighted by recent strategic moves from healthcare providers. In August 2024, ChristianaCare, a leading healthcare provider, and Atlas Healthcare Partners announced an exciting collaboration aimed at expanding access to cost-effective surgical care. The two organizations plan to develop a network of ASCs throughout Delaware and the Mid-Atlantic region. This collaboration highlights the increasing trend toward creating robust ASC networks to meet the demand for outpatient surgical care while maintaining high standards of quality and efficiency.
Meanwhile, Commons Clinic, a prominent player in the ASC landscape, made headlines in April 2024 with its announcement of a $9.75 million investment to expand its network of ASCs. This expansion will be driven by Commons Clinic’s proprietary surgical care platform, Theater, which aims to enhance the capabilities of its surgical centers. The investment reflects a broader industry trend where healthcare providers are dedicating resources to expand ASC networks and leverage advanced technology to further optimize surgical care delivery.
As the healthcare industry continues to embrace the cost-saving potential of ASCs, it is clear that these centers will play an increasingly vital role in the future of surgical care. With their ability to deliver high-quality procedures at a fraction of the cost of traditional hospital settings, ASCs are poised to reshape the surgical landscape in the coming years, supported by both economic trends and ongoing technological innovation.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/factors-influencing-the-ambulatory-surgical-center-industry
Invest in Our Premium Strategic Solution @ https://www.towardshealthcare.com/price/5021
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The medical imaging market is witnessing rapid expansion worldwide, and Europe is emerging as a key contributor to this global… Read More
The global continuous glucose monitoring devices market size is calculated at USD 4.97 in 2024. Living with diabetes in Canada… Read More
The surgical sutures market in the United States is showing steady and promising growth, and here’s why! 👇 👵👴 An… Read More
Azenta Life Sciences and Frenova, a division of Fresenius Medical Care and a leader in renal precision medicine, have announced… Read More
Zenara Pharma Private Limited, a leading Biophore company, has received final approval from the U.S. Food and Drug Administration (FDA)… Read More
Silexion Therapeutics Corp., a global clinical-stage biotech company specializing in RNA interference (RNAi) therapies, has announced outstanding new preclinical data… Read More